To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 65,806 shares, the number of shares held decreased 3.29% compared to the previous period and now represents 2.23% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in BioNTech SE by 3,978 shares, the number of shares held decreased 3.28% compared to the previous period and now represents 1% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 15,808 shares, the number of shares held decreased 3.28% compared to the previous period and now represents 0.64% of the total position.
      124Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 15,574 shares, the number of shares held decreased 3.28% compared to the previous period and now represents 3.67% of the total position.
      9Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in CareDx by 63,180 shares, the number of shares held decreased 3.29% compared to the previous period and now represents 3.44% of the total position.
      8Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 344,708 shares, the number of shares held decreased 3.29% compared to the previous period and now represents 1.43% of the total position.
      8.52K2
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 109,980 shares, the number of shares held decreased 3.29% compared to the previous period and now represents 3.85% of the total position.
      52Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Tempus AI by 65,962 shares, the number of shares held decreased 3.29% compared to the previous period and now represents 9.38% of the total position.
      22Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Alamar Biosciences by 18,746 shares, the number of shares held decreased 3.29% compared to the previous period and now represents 1.18% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 54,184 shares, the number of shares held decreased 3.29% compared to the previous period and now represents 2.36% of the total position.
      7Comment
      Report
       
       
       
       

      Most Discussed